In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer.

Background: Breast cancer is the most common type of cancer worldwide. Cyclin-dependent kinase inhibition is one of the backbones of metastatic breast cancer therapy. However, there are a significant number of therapy failures.

Expression of Prostate Specific Membrane Antigen (PSMA) in Breast Cancer.

Prostate specific membrane antigen (PSMA) is a promising protein for breast cancer patients. It has not only been detected in prostate cancer but is also expressed by tumor cells and the endothelial cells of tumor vessels in breast cancer patients. PSMA plays a role in tumor progression and tumor angiogenesis.